Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,437 | 83,222 | 163,873 | 16,274 | 23,695 |
| Marketable Securities | 112,967 | 124,233 | 61,983 | 68,219 | 74,363 |
| Receivables | 6,715 | 1,616 | 1,630 | 1,617 | 1,652 |
| Inventories | 5,493 | 4,850 | 2,686 | N/A | N/A |
| TOTAL | $204,906 | $216,130 | $232,262 | $88,121 | $100,853 |
| Non-Current Assets | |||||
| PPE Net | 9,921 | 10,338 | 9,489 | 6,947 | 4,430 |
| Other Non-Current Assets | 4,743 | 4,627 | 4,482 | 4,296 | 3,648 |
| TOTAL | $14,664 | $14,965 | $13,971 | $11,243 | $8,078 |
| Total Assets | $219,570 | $231,095 | $246,233 | $99,364 | $108,931 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,222 | 8,889 | 5,556 | 8,148 | 5,926 |
| Accounts payable and accrued liabilities | 7,889 | 5,927 | 7,337 | 5,018 | 3,441 |
| Accrued Expenses | 8,593 | 7,227 | 21,007 | 3,887 | 6,333 |
| Other current liabilities | 2 | 35 | 80 | 317 | 64 |
| TOTAL | $29,570 | $22,180 | $34,517 | $17,983 | $16,587 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,813 | 10,862 | 14,005 | 11,138 | 13,037 |
| Other Non-Current Liabilities | 22,971 | 26,820 | 34,135 | 28,847 | 35,276 |
| TOTAL | $30,784 | $37,682 | $48,140 | $39,985 | $48,313 |
| Total Liabilities | $60,354 | $59,862 | $82,657 | $57,968 | $64,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,049 | 54,191 | 51,279 | 51,157 | 48,534 |
| Common Shares | 550 | 524 | 512 | 490 | 457 |
| Retained earnings | -742,075 | -721,615 | -716,454 | -825,287 | -813,258 |
| Other shareholders' equity | 138 | 10 | -45 | -67 | 8 |
| TOTAL | $159,216 | $171,233 | $163,576 | $41,396 | $44,031 |
| Total Liabilities And Equity | $219,570 | $231,095 | $246,233 | $99,364 | $108,931 |